Literature DB >> 8207977

Expression of GATA-1 mRNA in human myeloid leukemic cells.

A Guerrasio1, G Saglio, C Rosso, A Alfarano, C Camaschella, F Lo Coco, A Biondi, A Rambaldi, S Nicolis, S Ottolenghi.   

Abstract

Expression of the transcription factor GATA-1, which regulates several erythroid specific genes and possibly also some megakaryocytic genes, has been previously detected in normal erythroblasts, megakaryocytes, and basophils, and in some myeloid cell lines. It has been suggested that GATA-1 may be first expressed in a common progenitor and then further activated during erythroid-megakaryocytic and basophilic differentiation and repressed during myeloid maturation. We investigated GATA-1 mRNA expression in highly purified leukemic blasts representing different lineages and stages of myeloid differentiation and in a recently established leukemic cell line, GF-D8, which exhibits morphological, cytochemical and immunophenotypic characteristics of early myeloid progenitor cells. We found GATA-1 expression in five of five myeloid and in one megakaryocytic blast crisis of CML, in four of six cases of myelomonocytic leukemias (M4 according to FAB classification), in one case of erythroleukemia (M6), whereas lymphoid blast crisis of CML and all other FAB groups were completely negative. In addition, a low level of GATA-1 mRNA was also expressed by the GF-D8 cell line. These data further support the hypothesis that GATA-1 expression may occur not only in erythroid and megakaryocytic progenitors, but also in early myeloid progenitors, and then be further regulated during lineage-specific maturation.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8207977

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


  3 in total

1.  PU.1 and pRB interact and cooperate to repress GATA-1 and block erythroid differentiation.

Authors:  Natasha Rekhtman; Kevin S Choe; Igor Matushansky; Stuart Murray; Tomas Stopka; Arthur I Skoultchi
Journal:  Mol Cell Biol       Date:  2003-11       Impact factor: 4.272

2.  Association of v-Ha-ras transgene expression with development of erythroleukemia in Tg.AC transgenic mice.

Authors:  C S Trempus; S Ward; G Farris; D Malarkey; R S Faircloth; R E Cannon; J F Mahler
Journal:  Am J Pathol       Date:  1998-07       Impact factor: 4.307

3.  A novel mouse model identifies cooperating mutations and therapeutic targets critical for chronic myeloid leukemia progression.

Authors:  George Giotopoulos; Louise van der Weyden; Hikari Osaki; Alistair G Rust; Paolo Gallipoli; Eshwar Meduri; Sarah J Horton; Wai-In Chan; Donna Foster; Rab K Prinjha; John E Pimanda; Daniel G Tenen; George S Vassiliou; Steffen Koschmieder; David J Adams; Brian J P Huntly
Journal:  J Exp Med       Date:  2015-08-24       Impact factor: 14.307

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.